(Circulation. 1996;94:817-823.)
© 1996 American Heart Association, Inc.
Articles |
HERG, a Primary Human Ventricular Target of the Nonsedating Antihistamine Terfenadine
the Rammelkamp Center for Research, MetroHealth Medical Center, Case Western Reserve University School of Medicine, Cleveland, Ohio.
Correspondence to Arthur M. Brown MD, PhD, Rammelkamp Center for Research, MetroHealth Medical Center, Case Western Reserve University School of Medicine, 2500 MetroHealth Dr, Cleveland, OH 44109-1998. E-mail abrown@mhnet.mhmc.org.
BackgroundAdministration of the antihistamine terfenadine (Seldane) to patients may result in acquired long QT syndrome and ventricular arrhythmias. One human cardiac target is Kv1.5, which expresses the ultrarapid outward K+ current (IKur) in atrium but may play only a minor role in ventricle. Another possible target is HERG, the human ether-a-go-go–related gene that expresses a delayed rectifier current (IKr) in human ventricle and produces hereditary long QT syndrome when defective.
Methods and ResultsWe therefore heterologously expressed Kv1.5 and HERG in Xenopus oocytes to compare the sensitivity of each to terfenadine. We found that HERG was 10 times more sensitive than Kv1.5 to terfenadine block. The apparent Kd values for HERG and Kv1.5 currents were 350 nmol/L and 2.7 µmol/L, respectively. These Kd values compare well with values reported for terfenadine block of IKr and IKur currents in human atrial myocytes. The Kd value for HERG block is relevant to the toxicity of the antihistamine, since the clinical terfenadine concentrations in human plasma may reach the 100 nmol/L range.
Conclusions Terfenadine carboxylate, the major metabolite of terfenadine, does not block either HERG or Kv1.5, which agrees with the hypothesis that the buildup of parent terfenadine is the likely explanation for its cardiotoxicity. We propose that the blocking of HERG by terfenadine explains the acquired long QT syndrome. HERG is likely to be the primary target for the known cardiotoxic effects of other, related antihistamines.
Key Words: terfenadine • ketoconazole • oocytes • delayed rectifier
This article has been cited by other articles:
 |
|
 |
|
  S. B. Ganapathi, M. Kester, and K. S. Elmslie State-dependent block of HERG potassium channels by R-roscovitine: implications for cancer therapy Am J Physiol Cell Physiol, April 1, 2009; 296(4): C701 - C710. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Sala, M. Lazzaretti, G. De Vidovich, E. Caverzasi, F. Barale, G. d'Allio, and P. Brambilla Electrophysiological changes of cardiac function during antidepressant treatment Therapeutic Advances in Cardiovascular Disease, February 1, 2009; 3(1): 29 - 43. [Abstract] [PDF]
|
|
|
|
 |
|
 J. C. Hancox and A. F. James Refining Insights into High-Affinity Drug Binding to the Human Ether-a-go-go-Related Gene Potassium Channel Mol. Pharmacol., June 1, 2008; 73(6): 1592 - 1595. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Hassel, E. P. Scholz, N. Trano, O. Friedrich, S. Just, B. Meder, D. L. Weiss, E. Zitron, S. Marquart, B. Vogel, et al. Deficient Zebrafish Ether-a-Go-Go-Related Gene Channel Gating Causes Short-QT Syndrome in Zebrafish Reggae Mutants Circulation, February 19, 2008; 117(7): 866 - 875. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. A. Gintant, Z. Su, R. L. Martin, and B. F. Cox Utility of hERG Assays as Surrogate Markers of Delayed Cardiac Repolarization and QT Safety Toxicol Pathol, January 1, 2006; 34(1): 81 - 90. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Brugada, K. Hong, J. M. Cordeiro, and R. Dumaine Short QT syndrome Can. Med. Assoc. J., November 22, 2005; 173(11): 1349 - 1354. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. C. Hebert, G. Desir, G. Giebisch, and W. Wang Molecular Diversity and Regulation of Renal Potassium Channels Physiol Rev, January 1, 2005; 85(1): 319 - 371. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Rezazadeh, J. C. Hesketh, and D. Fedida Rb+ Flux through hERG Channels Affects the Potency of Channel Blocking Drugs: Correlation with Data Obtained Using a High-Throughput Rb+ Efflux Assay J Biomol Screen, October 1, 2004; 9(7): 588 - 597. [Abstract] [PDF]
|
|
|
|
|
|
M. Perry, M. J. de Groot, R. Helliwell, D. Leishman, M. Tristani-Firouzi, M. C. Sanguinetti, and J. Mitcheson Structural Determinants of HERG Channel Block by Clofilium and Ibutilide Mol. Pharmacol., August 1, 2004; 66(2): 240 - 249. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. M. Mullins, S. Z. Stepanovic, N. B. Gillani, A. L. George Jr, and J. R. Balser Functional interaction between extracellular sodium, potassium and inactivation gating in HERG channels J. Physiol., August 1, 2004; 558(3): 729 - 744. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Hua and R. F. Gilmour Jr Contribution of IKr to Rate-Dependent Action Potential Dynamics in Canine Endocardium Circ. Res., April 2, 2004; 94(6): 810 - 819. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Kang, X.-L. Chen, H. Wang, J. Ji, W. Reynolds, S. Lim, J. Hendrix, and D. Rampe Cardiac Ion Channel Effects of Tolterodine J. Pharmacol. Exp. Ther., March 1, 2004; 308(3): 935 - 940. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Brugada, K. Hong, R. Dumaine, J. Cordeiro, F. Gaita, M. Borggrefe, T. M. Menendez, J. Brugada, G. D. Pollevick, C. Wolpert, et al. Sudden Death Associated With Short-QT Syndrome Linked to Mutations in HERG Circulation, January 6, 2004; 109(1): 30 - 35. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Gralinski The Dog's Role in the Preclinical Assessment of QT Interval Prolongation Toxicol Pathol, January 1, 2003; 31(1_suppl): 11 - 16. [Abstract] [PDF]
|
|
|
|
 |
|
 J. Wang, K. Della Penna, H. Wang, J. Karczewski, T. M. Connolly, K. S. Koblan, P. B. Bennett, and J. J. Salata Functional and pharmacological properties of canine ERG potassium channels Am J Physiol Heart Circ Physiol, January 1, 2003; 284(1): H256 - H267. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. M. Mullins, S. Z. Stepanovic, R. R. Desai, A. L. George Jr., and J. R. Balser Extracellular Sodium Interacts with the HERG Channel at an Outer Pore Site J. Gen. Physiol., September 30, 2002; 120(4): 517 - 537. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-E. Chiang, H.-N. Luk, T.-M. Wang, and P. Y.-A. Ding Effects of sildenafil on cardiac repolarization Cardiovasc Res, August 1, 2002; 55(2): 290 - 299. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. D. Gbadebo, R. W. Trimble, M. S.C. Khoo, J. Temple, D. M. Roden, and M. E. Anderson Calmodulin Inhibitor W-7 Unmasks a Novel Electrocardiographic Parameter That Predicts Initiation of Torsade de Pointes Circulation, February 12, 2002; 105(6): 770 - 774. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Ficker, W. Jarolimek, and A. M. Brown Molecular Determinants of Inactivation and Dofetilide Block in ether a-go-go (EAG) Channels and EAG-Related K+ Channels Mol. Pharmacol., December 1, 2001; 60(6): 1343 - 1348. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Tang, J. Kang, X. Wu, D. Rampe, L. Wang, H. Shen, Z. Li, D. Dunnington, and T. Garyantes Development and Evaluation of High Throughput Functional Assay Methods for hERG Potassium Channel J Biomol Screen, October 1, 2001; 6(5): 325 - 331. [Abstract] [PDF]
|
|
|
|
|
|
J. Kang, X.-L. Chen, L. Wang, and D. Rampe Interactions of the Antimalarial Drug Mefloquine with the Human Cardiac Potassium Channels KvLQT1/minK and HERG J. Pharmacol. Exp. Ther., October 1, 2001; 299(1): 290 - 296. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.E. Lacerda, J. Kramer, K.-Z. Shen, D. Thomas, and A.M. Brown Comparison of block among cloned cardiac potassium channels by non-antiarrhythmic drugs Eur. Heart J. Suppl., September 1, 2001; 3(suppl_K): K23 - K30. [Abstract] [PDF]
|
|
|
|
|
|
M.R. Rosen Isolated tissue models and proarrhythmia Eur. Heart J. Suppl., September 1, 2001; 3(suppl_K): K64 - K69. [Abstract] [PDF]
|
|
|
|
|
|
J. Kang, L. Wang, X.-L. Chen, D. J. Triggle, and D. Rampe Interactions of a Series of Fluoroquinolone Antibacterial Drugs with the Human Cardiac K+ Channel HERG Mol. Pharmacol., January 1, 2001; 59(1): 122 - 126. [Abstract] [Full Text]
|
|
|
|
|
|
H. Numaguchi, F. M. Mullins, J. P. Johnson Jr., D. C. Johns, S. S. Po, I. C.-H. Yang, G. F. Tomaselli, and J. R. Balser Probing the Interaction Between Inactivation Gating and Dd-Sotalol Block of HERG Circ. Res., November 24, 2000; 87(11): 1012 - 1018. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Secondo, M. Taglialatela, M. Cataldi, G. Giorgio, M. Valore, G. Di Renzo, and L. Annunziato Pharmacological Blockade of ERG K+ Channels and Ca2+ Influx through Store-Operated Channels Exerts Opposite Effects on Intracellular Ca2+ Oscillations in Pituitary GH3 Cells Mol. Pharmacol., November 1, 2000; 58(5): 1115 - 1128. [Abstract] [Full Text]
|
|
|
|
 |
|
 W Haverkamp, G Breithardt, A.J Camm, M.J Janse, M.R Rosen, C Antzelevitch, D Escande, M Franz, M Malik, A Moss, et al. The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology Eur. Heart J., August 1, 2000; 21(15): 1216 - 1231. [PDF]
|
|
|
|
|
|
W. Haverkamp, G. Breithardt, A.J. Camm, M. J Janse, M. R Rosen, C. Antzelevitch, D. Escande, M. Franz, M. Malik, A. Moss, et al. The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: Clinical and regulatory implications: Report on a Policy Conference of the European Society of Cardiology Cardiovasc Res, August 1, 2000; 47(2): 219 - 233. [Full Text] [PDF]
|
|
|
|
|
|
W. J. Crumb Jr. Loratadine Blockade of K+ Channels in Human Heart: Comparison with Terfenadine under Physiological Conditions J. Pharmacol. Exp. Ther., January 1, 2000; 292(1): 261 - 264. [Abstract] [Full Text]
|
|
|
|
|
|
C. Ulens, P. Daenens, and J. Tytgat Norpropoxyphene-induced cardiotoxicity is associated with changes in ion-selectivity and gating of HERG currents Cardiovasc Res, December 1, 1999; 44(3): 568 - 578. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-Z. Wang, H. Shi, S.-J. Liao, and Z. Wang Inactivation gating determines nicotine blockade of human HERG channels Am J Physiol Heart Circ Physiol, September 1, 1999; 277(3): H1081 - H1088. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Nishio, Y. Habuchi, H. Tanaka, J. Morikawa, T. Yamamoto, and K. Kashima Blockage by Terfenadine of the Adenosine Triphosphate (ATP)-Sensitive K+ Current in Rabbit Ventricular Myocytes J. Pharmacol. Exp. Ther., October 1, 1998; 287(1): 293 - 300. [Abstract] [Full Text]
|
|
|
|
|
|
R. Dumaine, M.-L. Roy, and A. M. Brown Blockade of HERG and Kv1.5 by Ketoconazole J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 727 - 735. [Abstract] [Full Text]
|
|
|
|
|
|
D. Rampe, M. K. Murawsky, J. Grau, and E. W. Lewis The Antipsychotic Agent Sertindole is a High Affinity Antagonist of the Human Cardiac Potassium Channel HERG J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 788 - 793. [Abstract] [Full Text]
|
|
|
|
|
|
M. Taglialatela, A. Pannaccione, P. Castaldo, G. Giorgio, Z. Zhou, C. T. January, A. Genovese, G. Marone, and L. Annunziato Molecular Basis for the Lack of HERG K+ Channel Block-Related Cardiotoxicity by the H1 Receptor Blocker Cetirizine Compared with Other Second-Generation Antihistamines Mol. Pharmacol., July 1, 1998; 54(1): 113 - 121. [Abstract] [Full Text]
|
|
|
|
|
|
S. Nattel Experimental evidence for proarrhythmic mechanisms of antiarrhythmic drugs Cardiovasc Res, March 1, 1998; 37(3): 567 - 577. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. D. West, D. K. Martin, J. A. Bursill, K. R. Wyse, and T. J. Campbell Comparative Study of the Effects of Erythromycin and Roxithromycin on Action Potential Duration and Potassium Currents in Canine Purkinje Fibers and Rabbit Myocardium Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1998; 3(1): 29 - 36. [Abstract] [PDF]
|
|
|
|
|
|
S. Mohammad, Z. Zhou, Q. Gong, and C. T. January Blockage of the HERG human cardiac K+ channel by the gastrointestinal prokinetic agent cisapride Am J Physiol Heart Circ Physiol, November 1, 1997; 273(5): H2534 - H2538. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Taglialatela, P. Castaldo, S. Iossa, A. Pannaccione, A. Fresi, E. Ficker, and L. Annunziato Regulation of the human ether-a-gogo related gene (HERG) K+ channels by reactive oxygen species PNAS, October 14, 1997; 94(21): 11698 - 11703. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Liu, R. B. Melchert, and R. H. Kennedy Inhibition of L-Type Ca2+ Channel Current in Rat Ventricular Myocytes by Terfenadine Circ. Res., August 19, 1997; 81(2): 202 - 210. [Abstract] [Full Text]
|
|
|
|
|
|
A. E. Lacerda, M.-L. Roy, E. W. Lewis, and D. Rampe Interactions of the Nonsedating Antihistamine Loratadine with a Kv1.5-Type Potassium Channel Cloned from Human Heart Mol. Pharmacol., August 1, 1997; 52(2): 314 - 322. [Abstract] [Full Text]
|
|
|
|
|
|
M. R. Rosen Of Oocytes and Runny Noses Circulation, August 15, 1996; 94(4): 607 - 609. [Full Text]
|
|